你即將離開本站

並前往https://www.pfizer.com/news/press-release/press-release-detail/pfizers-novel-covid-19-oral-antiviral-treatment-candidate

Pfizer's Novel COVID-19 Oral Antiviral Treatment Candidate

PAXLOVID™ (PF-07321332; ritonavir) was found to reduce the risk of hospitalization or death by 89% compared to placebo in non-hospitalized ...

確定！ 回上一頁

查詢 「fatality rate中文」的人也找了：